(MedPage Today) — The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday.
The prefilled syringe formulation…
Source link : https://www.medpagetoday.com/neurology/migraines/115625
Author :
Publish date : 2025-05-16 18:13:00
Copyright for syndicated content belongs to the linked Source.
